Wohl & Fruchter LLP

Call Us 866-833-6245

  • About
  • Attorneys
  • Practice Areas
  • Cases
  • Results
  • News
  • Contact
  1. Home
  2. Cases
  3. Varonis

Varonis

We are investigating the fairness of the proposed sale of Varonis Systems, Inc. (NASDAQ: VRNS) (“Varonis”) to Proofpoint, Inc. for $49.75 per share in cash.

Notably, the $49.75 sale price is below Varonis’s 52-week high of $63.80, which potentially indicates an opportunistic purchase below fair value.

In addition, the sale price is below the price targets of multiple Wall Street analysts covering Varonis before the sale was announced, including:

  • Joseph Gallo of Jefferies ($60.00 price target)
  • Rob Owens of Piper Sandler ($58.00 price target)
  • Shaul Eyal of TD Cowen ($56.00 price target)
  • Erik Suppiger of B. Riley Securities ($55.00 price target)
  • Mike Cikos of Needham ($55.00 price target)

(Source: TipRanks)

If you remain a Varonis shareholder and have concerns about the fairness of the proposed sale, you may contact our firm by completing and submitting the form below.

“We are investigating whether the Varonis Board of Directors acted in the best interests of Varonis shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the cash consideration agreed upon is fair to Varonis shareholders and whether all material information regarding the transaction has been fully disclosed. We encourage Varonis shareholders to contact us if they have any concerns.”

Contact Us About This Case

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
If you lost money, enter $ amount, and hit "tab" to verify. If you have a gain, enter $0.
Please check box*
Click to Contact Us About This Case

Attorney

Joshua Fruchter
845-290-6818
alerts@wohlfruchter.com

  • Legal
  • Privacy Policy
  • Sitemap
  • Contact

Attorney Advertising. Prior results do not guarantee a similar outcome.

© 2026 Wohl & Fruchter LLP